|
Market Closed -
London S.E.
11:35:28 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 81.00 GBX | +4.52% |
|
+5.88% | +0.62% |
| 08-13 | EARNINGS AND TRADING: tinybuild sues Max Ent; Light Science loss grows | AN |
| 08-13 | Arecor Therapeutics plc Publishes Clinical Data for AT278 in Peer-Reviewed Journal | CI |
| Market Cap | 30.58M 41.36M 35.63M 33.74M 57.38M 3.95B 57.67M 401M 154M 2.01B 155M 152M 6.35B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 29.26M 39.57M 34.1M 32.28M 54.9M 3.78B 55.18M 383M 147M 1.92B 149M 145M 6.08B | EV / Sales 2026 * |
33.3x | EV / Sales 2027 * | 32.2x |
| Free-Float |
46.91% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AREC | Delayed | |
Deutsche Boerse AG
| 6UI | Delayed | |
|
Börse Stuttgart
| 6UI | Delayed |
Last Transcript : Arecor Therapeutics plc
| 1 day | +4.52% | ||
| 1 week | +5.88% | ||
| Current month | +9.46% | ||
| 1 month | +36.13% | ||
| 3 months | +24.62% | ||
| 6 months | +12.50% | ||
| Current year | +0.62% |
| 1 week | 75 |  | 85 |
| 1 month | 57 | | 85 |
| Current year | 55.27 | | 95 |
| 1 year | 55.27 | | 100 |
| 3 years | 35.4 | | 199 |
| 5 years | 35.4 | | 472 |
| 10 years | 35.4 | | 472 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 51 | 2021-04-12 |
David J. Ellam
DFI | Director of Finance/CFO | - | 2024-11-17 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 2007-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sarah Howell
BRD | Director/Board Member | 51 | 2021-04-12 |
Mohammad Fazeli
BRD | Director/Board Member | 61 | 2017-08-31 |
Andrew Richards
CHM | Chairman | 66 | 2021-04-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/20/26 | Free | Chief Executive Officer | 160,000 | 0.4238% | ||
| 5/20/26 | Free | Executive/Senior Manager | 95,000 | 0.2516% | ||
| 5/20/26 | Free | Chief Financial Officer | 105,000 | 0.2781% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.52% | +5.88% | +11.72% | -56.80% | 41.36M | |
| -0.71% | -6.35% | -4.87% | +9.03% | 45.48B | |
| +0.21% | -2.98% | +340.68% | +519.93% | 43.69B | |
| +1.74% | -2.24% | +37.28% | +21.57% | 43.09B | |
| +1.38% | -3.28% | +3.23% | +65.60% | 39.4B | |
| -1.44% | -5.26% | +8.78% | +36.85% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +18.07% | +110.32% | 16.4B | |
| -0.31% | -2.78% | +10.47% | +30.49% | 14.24B | |
| +1.93% | -3.55% | +74.20% | +39.37% | 13.28B | |
| Average | +0.89% | -2.63% | +55.51% | +86.26% | 26.48B | |
| Weighted average by Cap. | +0.41% | -3.66% | +73.15% | +123.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 878K 1.19M 1.02M 969K 1.65M 113M 1.66M 11.51M 4.43M 57.74M 4.46M 4.36M 182M | 1.05M 1.42M 1.22M 1.16M 1.97M 136M 1.98M 13.76M 5.29M 69.02M 5.33M 5.22M 218M |
| Net income | - | - |
| Net Debt | -1.32M -1.78M -1.54M -1.46M -2.48M -171M -2.49M -17.29M -6.65M -86.75M -6.7M -6.56M -274M | 3.2M 4.33M 3.73M 3.53M 6.01M 414M 6.04M 41.97M 16.14M 211M 16.27M 15.91M 665M |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | GBX 81.00 | +4.52% | 12,706 |
| 26-09-10 | GBX 77.50 | 0.00% | 8,132 |
| 26-09-09 | GBX 77.50 | 0.00% | 10,644 |
| 26-09-08 | GBX 77.50 | 0.00% | 40,019 |
| 26-09-07 | GBX 77.50 | +1.31% | 43,023 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.8100GBP
Average target price
2.755GBP
Spread / Average Target
+240.12%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AREC Stock
Select your edition
All financial news and data tailored to specific country editions
